Genflow Biosciences PLC at OTC Markets Life Science Investor Forum Transcript
Hello, and welcome to our virtual investor conferences. My name is Eric May. And on behalf of OTC Markets, we're very pleased you have joined us for our next slide presentation from Genflow Biosciences, a biotech company focused on developing gene therapies that target the aging process. (Event Instructions)
At this point, I'm very pleased to welcome Eric Leire, Founder and CEO of Genflow Biosciences PLC, which trades on the OTCQB Venture Market under the symbol GENFF and also on the LSE under the symbol GENF. Welcome, Eric.
Thank you, Eric. And thank you, the audience, for joining this presentation. I assume you won't be surprised if I make forward-looking statement, I can skip that and start presenting the company. Genflow is an anti-aging company. What does that mean? And you may be surprised to see a biotech company addressing aging. Aging is considered a fatality, not as a disease.
In fact, we should be very interested in aging.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |